Dow Up0.51% Nasdaq Up0.24%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
2.95 0.00(0.00%) Nov 21, 4:00PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.25N/A-0.95-1.01
No. of Analysts2.00N/A2.002.00
Low Estimate-0.26N/A-0.96-1.10
High Estimate-0.23N/A-0.93-0.92
Year Ago EPS-0.19-0.25-1.28-0.95
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate80.00KNaN1.28M250.00K
No. of Analysts222
Low EstimateNaNNaN1.05MNaN
High Estimate150.00KNaN1.50M500.00K
Year Ago Sales299.00KNaN1.08M1.28M
Sales Growth (year/est)-73.20%N/A18.10%-80.50%
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est-0.33-0.26-0.30-0.26
EPS Actual-0.19-0.25-0.22-0.22
Difference0.140.010.080.04
Surprise %42.40%3.80%26.70%15.40%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.25N/A-0.95-1.01
7 Days Ago-0.25N/A-0.95-1.01
30 Days Ago-0.26N/A-1.01-1.02
60 Days Ago-0.26N/A-1.01-1.02
90 Days Ago-0.26N/A-1.01-1.02
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0N/A11
Up Last 30 Days0N/A11
Down Last 30 Days0N/A00
Down Last 90 DaysN/AN/AN/AN/A
Growth EstCYCCIndustrySectorS&P 500
Current Qtr.-31.60%N/A-73.50%19.10%
Next Qtr.N/AN/A-36.60%19.20%
This Year25.80%N/A31.50%8.00%
Next Year-6.30%N/A22.00%10.70%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A14.19%14.41%9.84%
Price/Earnings (avg. for comparison categories)-3.11-10.644.5120.95
PEG Ratio (avg. for comparison categories)N/A10.623.622.33
Currency in USD.